Literature DB >> 30026525

Genetic disorders: PI3K inhibitor reverses overgrowth syndrome.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2018        PMID： 30026525     DOI： 10.1038/nrd.2018.120

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Targeted therapy in patients with PIK3CA-related overgrowth syndrome.

Authors:  Quitterie Venot; Thomas Blanc; Smail Hadj Rabia; Laureline Berteloot; Sophia Ladraa; Jean-Paul Duong; Estelle Blanc; Simon C Johnson; Clément Hoguin; Olivia Boccara; Sabine Sarnacki; Nathalie Boddaert; Stephanie Pannier; Frank Martinez; Sato Magassa; Junna Yamaguchi; Bertrand Knebelmann; Pierre Merville; Nicolas Grenier; Dominique Joly; Valérie Cormier-Daire; Caroline Michot; Christine Bole-Feysot; Arnaud Picard; Véronique Soupre; Stanislas Lyonnet; Jeremy Sadoine; Lotfi Slimani; Catherine Chaussain; Cécile Laroche-Raynaud; Laurent Guibaud; Christine Broissand; Jeanne Amiel; Christophe Legendre; Fabiola Terzi; Guillaume Canaud
Journal:  Nature       Date:  2018-06-13       Impact factor: 49.962
  1 in total
  1 in total

Review 1.  PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects.

Authors:  Rosalin Mishra; Hima Patel; Samar Alanazi; Mary Kate Kilroy; Joan T Garrett
Journal:  Int J Mol Sci       Date:  2021-03-27       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.